LifeVac, LLC
Letter data
- Company
- LifeVac, LLC
- Recipient
- Mr. Arthur Lih | CEO | LifeVac, LLC | 110 Lake Avenue South Ste 35 | Nesconset | , | NY | 11767-1071 | United States | alih@lifevac.net
- Issue date
- 2026-03-04
- Posted date
- Not available
- FDA office
- Center for Devices and Radiological Health
- Subject
- Not available
- Product
- Medical Devices | Ear, Nose & Throat
- CMS ID
- 713455
- Reference number
- Not available
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
LifeVac, LLC
MARCS-CMS 713455 —
March 04, 2026
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Product:
Medical Devices
Ear, Nose & Throat
Recipient:
Recipient Name
Mr. Arthur Lih
Recipient Title
CEO
LifeVac, LLC
110 Lake Avenue South Ste 35
Nesconset
,
NY
11767-1071
United States
alih@lifevac.net
Issuing Office:
Center for Devices and Radiological Health
United States
Secondary Issuing Offices
United States
March 4, 2026
Dear Mr. Lih:
The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter (CMS # 713455, dated September 18, 2025). Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/s/
Srinivas Nandkumar, Ph.D.
Director,
Division of Dental and ENT Devices,
Office of Health Technology 1, Ophthalmic,
Anesthesia, Respiratory, ENT & Dental Devices
Center for Devices and Radiological Health
Content current as of:
03/04/2026
Regulated Product(s)
Medical Devices
Ear, Nose & Throat